Posted by ABMN Staff on Mar 29th, 2024
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) CEO Samuel Kintz sold 12,000 shares of Enliven Therapeutics stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $17.56, for a total...
More of this article »